Searching recalls…
Searching…
Home › Cleaning & chemicals › Genentech Prescription Drug Evrysdi
Product recall · CPSCMarch 18, 2021Worth checking
Genentech Prescription Drug Evrysdi
Check whether yours is affected, then follow the instructions below.
What’s wrong
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
The Recall Registry rates this worth checking — we found nothing in the notice describing a specific injury. A recall covers only the versions, UPCs or date codes it names, so check those against yours.
What it looks like
Photos help. Identifiers decide. Appearance can vary by color, finish or packaging. Confirm the model number, date code or other identifier in the official notice.
Recall image provided by CPSC
What to do
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Who to contact: Genentech at 800-334-0290 from 8 a.m. to 8 p.m. ET Monday through Friday or online at www.Evrysdi.com and click on the "leaking bottles safety information" banner on the homepage for more information.
The product
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Details
- Units affected
- About 14,000
- Recall date
- March 18, 2021
- Brand
- Genentech, a member of the Roche Group, of South San Francisco, Calif.
- Injuries reported
- None reported
- What has been reported
- Genentech has received 26 reports of leaking bottles. No injuries have been reported.
Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
The official notice
This recall was issued by the U.S. Consumer Product Safety Commission. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert)”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Cleaning & chemicals